Issue 11/2014
Content (23 Articles)
Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations
Elisabetta Patorno, Amanda R. Patrick, Elizabeth M. Garry, Sebastian Schneeweiss, Victoria G. Gillet, Dorothee B. Bartels, Elvira Masso-Gonzalez, John D. Seeger
RANKL–OPG and RAGE modulation in vascular calcification and diabetes: novel targets for therapy
Agbor Ndip, Fiona L. Wilkinson, Edward B. Jude, Andrew J. M. Boulton, M. Yvonne Alexander
Prediabetes and the risk of cancer: a meta-analysis
Yi Huang, Xiaoyan Cai, Miaozhen Qiu, Peisong Chen, Hongfeng Tang, Yunzhao Hu, Yuli Huang
Does genetic heterogeneity account for the divergent risk of type 2 diabetes in South Asian and white European populations?
Zahra N. Sohani, Wei Q. Deng, Guillaume Pare, David Meyre, Hertzel C. Gerstein, Sonia S. Anand
Metabolite signatures of exercise training in human skeletal muscle relate to mitochondrial remodelling and cardiometabolic fitness
Kim M. Huffman, Timothy R. Koves, Monica J. Hubal, Hiba Abouassi, Nina Beri, Lori A. Bateman, Robert D. Stevens, Olga R. Ilkayeva, Eric P. Hoffman, Deborah M. Muoio, William E. Kraus
Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
Michael C. d’Emden, Alicia J. Jenkins, Liping Li, Diana Zannino, Kristy P. Mann, James D. Best, Bronwyn G. A. Stuckey, Kris Park, Juha Saltevo, Anthony C. Keech
Predicting major outcomes in type 1 diabetes: a model development and validation study
Sabita S. Soedamah-Muthu, Yvonne Vergouwe, Tina Costacou, Rachel G. Miller, Janice Zgibor, Nish Chaturvedi, Janet K. Snell-Bergeon, David M. Maahs, Marian Rewers, Carol Forsblom, Valma Harjutsalo, Per-Henrik Groop, John H. Fuller, Karel G. M. Moons, Trevor J. Orchard
Higher dietary salt intake is associated with microalbuminuria, but not with retinopathy in individuals with type 1 diabetes: the EURODIAB Prospective Complications Study
Lian Engelen, Sabita S. Soedamah-Muthu, Johanna M. Geleijnse, Monika Toeller, Nish Chaturvedi, John H. Fuller, Casper G. Schalkwijk, Coen D. A. Stehouwer
Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly diagnosed type 2 diabetes mellitus: The Basque Country Prospective Complications and Mortality Study risk engine (BASCORE)
José A. Piniés, Fernando González-Carril, José M. Arteagoitia, Itziar Irigoien, Jone M. Altzibar, José L. Rodriguez-Murua, Larraitz Echevarriarteun
Variants associated with type 2 diabetes identified by the transethnic meta-analysis study: assessment in American Indians and evidence for a new signal in LPP
Anup K. Nair, Yunhua Li Muller, Nellie A. McLean, Maryam Abdussamad, Paolo Piaggi, Sayuko Kobes, E. Jennifer Weil, Jeffrey M. Curtis, Robert G. Nelson, William C. Knowler, Robert L. Hanson, Leslie J. Baier
Non-neural tyrosine hydroxylase, via modulation of endocrine pancreatic precursors, is required for normal development of beta cells in the mouse pancreas
Patricia Vázquez, Ana M. Robles, Flora de Pablo, Catalina Hernández-Sánchez
von Hippel–Lindau gene disruption in mouse pancreatic progenitors and its consequences on endocrine differentiation in vivo: importance of HIF1-α and VEGF-A upregulation
Andrea Soggia, Cyrille Ramond, Haruhiko Akiyama, Raphaël Scharfmann, Bertrand Duvillie
In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone
Jørn P. Lindahl, Finn P. Reinholt, Ivar A. Eide, Anders Hartmann, Karsten Midtvedt, Hallvard Holdaas, Linda T. Dorg, Trine M. Reine, Svein O. Kolset, Rune Horneland, Ole Øyen, Knut Brabrand, Trond Jenssen
A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice
Gisela M. Vaitaitis, Michael H. Olmstead, Dan M. Waid, Jessica R. Carter, David H. Wagner Jr.
Global DNA methylation levels in human adipose tissue are related to fat distribution and glucose homeostasis
Maria Keller, Susan Kralisch, Kerstin Rohde, Dorit Schleinitz, Arne Dietrich, Michael R. Schön, Daniel Gärtner, Tobias Lohmann, Miriam Dreßler, Anke Tönjes, Michael Stumvoll, Peter Kovacs, Mathias Fasshauer, Matthias Blüher, Yvonne Böttcher
Downregulation of the acetyl-CoA metabolic network in adipose tissue of obese diabetic individuals and recovery after weight loss
Harish Dharuri, Peter A. C. ’t Hoen, Jan B. van Klinken, Peter Henneman, Jeroen F. J. Laros, Mirjam A. Lips, Fatiha el Bouazzaoui, Gert-Jan B. van Ommen, Ignace Janssen, Bert van Ramshorst, Bert A. van Wagensveld, Hanno Pijl, Ko Willems van Dijk, Vanessa van Harmelen
Macrophage mTORC1 disruption reduces inflammation and insulin resistance in obese mice
Hongfeng Jiang, Marit Westerterp, Chunjiong Wang, Yi Zhu, Ding Ai
The coactivator PGC-1α regulates skeletal muscle oxidative metabolism independently of the nuclear receptor PPARβ/δ in sedentary mice fed a regular chow diet
Joaquín Pérez-Schindler, Kristoffer Svensson, Elyzabeth Vargas-Fernández, Gesa Santos, Walter Wahli, Christoph Handschin
A low disposition index in adolescent offspring of mothers with gestational diabetes: a risk marker for the development of impaired glucose tolerance in youth
Tara Holder, Cosimo Giannini, Nicola Santoro, Bridget Pierpont, Melissa Shaw, Elvira Duran, Sonia Caprio, Ram Weiss
Neurogenin 3 is important but not essential for pancreatic islet development in humans
Oscar Rubio-Cabezas, Ethel Codner, Sarah E. Flanagan, José L. Gómez, Sian Ellard, Andrew T. Hattersley
Timing and intensity of exercise for glucose control. Reply to Chacko E. [letter]
Frank W. Booth, John P. Thyfault
Erratum to: Denatonium induces secretion of glucagon-like peptide-1 through activation of bitter taste receptor pathways
Ki-Suk Kim, Josephine M. Egan, Hyeung-Jin Jang